# Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

> **NCT01134315** · — · TERMINATED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 61 (actual)

## Conditions studied

- Secondary Hyperparathyroidism
- End-Stage Renal Disease

## Interventions

- **DRUG:** Paricalcitol
- **DRUG:** Calcitriol

## Key facts

- **NCT ID:** NCT01134315
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 61 (ACTUAL)
- **Why stopped:** Terminated after FDA agreement.
- **Last updated:** 2013-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134315, "Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01134315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*